Division of Rheumatology

【Growth Process】

On October 1, 1984, the Cadre Department was established independently and the first cadre ward in Fuyang District was established. It is located on the 17th floor of the old ward building and has 30 open beds. In 2005, the first case of manual reduction of benign positional vertigo in Fuyang District was carried out (main developer: Wu Zhenxia). In 2012, our hospital started biological agent treatment for rheumatoid arthritis (main developer: Wen Li). In 2013, our hospital started treatment for ankylosing spine. Biological agent treatment of rheumatoid arthritis (main developer: Wen Li) In June 2015, with the overall relocation of the hospital, the Rheumatology and Immunology Geriatric (cadre) Department was established, located on the 15th floor of the inpatient building, with 43 beds. In 2015, the first case of thrombolytic treatment for ischemic stroke in Fuyang District was carried out (main developer: Wu Zhenxia). In 2015, the first case of botulinum toxin treatment for hemifacial spasm was carried out in Fuyang District (main developer: Wu Zhenxia). In 2015, our hospital carried out Biological agent treatment of psoriasis (main developer: Wen Li) In 2016, the first VHIT examination for vestibular disease in Fuyang District was carried out (main developer: Wu Zhenxia) In 2018, dizziness (vertigo) clinic, memory clinic, and gout clinic were launched In 2020, our hospital will carry out labial gland biopsy technology to assist in the diagnosis of Sjögren's syndrome in specialized outpatient clinics. (Main developers: Wen Li, etc.) A vertigo diagnosis and treatment center will be established in 2020. (Main developer: Wu Zhenxia, etc.) In 2021, the internationally advanced SRM-IV vertigo diagnosis and treatment system will be introduced to carry out the first machine repositioning treatment of otolithiasis in Fuyang District (Main developer: Wu Zhenxia, etc.) In 2021, new technology will be launched: foaming experimental microplugs The significance of sub-detection in the diagnosis of the cause of cerebral infarction. (Main developer: Wu Zhenxia, etc.) Starting from 2021, the application of biological agents in psoriatic arthritis and ankylosing spondylitis will be carried out. (Main initiator: Wen Li, etc.) In 2021, we will undertake the municipal continuing medical education project "Standardized Diagnosis and Treatment of Dizziness Diseases in Primary-level Hospitals under the Medical Community Model" (Main Person in Charge: Wu Zhenxia, etc.) In 2022, we will establish a specialized dizziness center ( main in-charge: Wu Zhenxia, etc.) In 2022, we will host the municipal continuing medical education project "Study Class on New Progress in Geriatric Chronic Disease Management in Primary Hospitals under the Medical Community Model". (Main person in charge: Wu Zhenxia, etc.) In 2022, the application of biological agents in systemic lupus erythematosus and the application of anti-fibrotic drugs in immune-related interstitial lung disease will be carried out, which will significantly improve the therapeutic effect of rheumatic immune diseases. (Main developers: Wen Li, etc.) From 2021 to 2023, a doctoral workstation for neurological diseases and rheumatic immune diseases will be launched. (Main developers: Wu Zhenxia-Gui Yaxing, Wenli-Xue Jing, etc.) In 2023, we will undertake the provincial continuing medical education project "Standardized Diagnosis and Treatment of Dizziness Diseases in Primary Hospitals under the Medical Community Model". (Main person in charge: Wu Zhenxia, etc.) New technology will be launched in 2023: the magical "space journey" - the application of SRM-IV diagnosis and treatment system in vertigo diseases. (Main person in charge: Wu Zhenxia, etc.) A specialized center for spondyloarthritis will be established in 2023 to make specialist diagnosis and treatment more refined. (Main developers: Wen Li, etc.)

[Successive directors and head nurses]

The Rheumatology and Immunology Geriatric (Cadre) Department was formerly known as the Cadre Department. It was established on October 1, 1984. It has been more than 30 years since its establishment. After several generations of unremitting efforts and hard work, it has gradually developed and expanded. It has 48 beds, including 3 single rooms. And 1 dry care ward. The department has the most advanced Danish ICSImpulse technology and the internationally advanced SRM-IV vertigo diagnosis and treatment system. It has set up a vestibular function examination room, established a vertigo diagnosis and treatment center, and is equipped with directional traditional Chinese medicine treatment. instrument, defibrillation monitor, air pressure therapy instrument and other advanced equipment. Currently, there are 12 doctors in the department, including 1 chief physician, 3 deputy chief physicians, 4 attending physicians, and 4 residents, including 5 master's students. The department focuses on the diagnosis and treatment of vertigo, cerebrovascular diseases, rheumatic diseases and geriatric diseases. Responsible for the hospital's resident physician training and related teaching and intern training at Zhejiang University of Traditional Chinese Medicine.

【Diagnosis and treatment scope】

Diagnosis and treatment of cerebrovascular disease, vertigo, peripheral neuropathy, epilepsy, central nervous system infection, demyelinating disease, diagnosis and treatment of various vertigo diseases, manual reduction of benign positional vertigo, vestibular function examination; rheumatoid arthritis, systemic erythema Diagnosis and treatment of lupus, gout, ankylosing spondylitis, Sjogren's syndrome, diabetes, coronary heart disease, hypertension, chronic obstructive pulmonary disease, etc., articular puncture injection treatment, biologic treatment of rheumatic diseases, labial gland biopsy in Sjögren's syndrome Applications in Diagnosis.

【Technical Features】

Diagnosis and treatment of cardiovascular and cerebrovascular diseases, vestibular system diseases, rheumatism and immune diseases.

【Scientific research results】

The department now has 2 doctoral workstations, established and completed 3 municipal-level projects, 2 municipal-level continuing education projects, 1 provincial-level continuing education project, launched 7 new technology and new projects, and published more than 20 academic papers, including SCI 6 articles.